Gabapentin is NOT FDA-approved for anxiety and lacks high-quality evidence supporting its use for this indication
The evidence provided does not support gabapentin as a treatment for generalized anxiety disorder or chronic anxiety conditions. All available guidelines and FDA labeling indicate gabapentin is approved only for postherpetic neuralgia and epilepsy with partial onset seizures 1. The dosing information in these sources pertains exclusively to these approved indications, not anxiety.
Critical Evidence Gap
The guidelines provided 2 focus entirely on neuropathic pain management, not anxiety disorders. While one guideline mentions duloxetine has efficacy in "generalized anxiety disorder" 2, gabapentin is never recommended for anxiety in any of the clinical practice guidelines provided.
The pediatric anxiety guideline 3 recommends SSRIs and CBT for anxiety disorders in children and adolescents, with no mention of gabapentin as a treatment option.
Research Evidence Shows Only Preoperative Anxiolysis
The research studies 4, 5, 6, 7 examined gabapentin for acute preoperative anxiety only—a fundamentally different clinical scenario than treating chronic anxiety disorders:
- Single-dose studies used 1200 mg administered 2-3 hours before surgery 4, 5, 6, 7
- One negative study used 600 mg and found no anxiety reduction 8
- These were one-time administrations, not chronic dosing regimens
- The context was situational anxiety before a medical procedure, not generalized anxiety disorder
This evidence cannot be extrapolated to chronic anxiety treatment. The pharmacology, dosing frequency, duration of treatment, and clinical context are entirely different.
FDA-Approved Dosing (Not for Anxiety)
For the approved indications 1:
Postherpetic Neuralgia:
- Day 1: 300 mg once
- Day 2: 300 mg twice daily
- Day 3: 300 mg three times daily
- Titrate to 1800 mg/day (600 mg three times daily)
- Maximum studied: 3600 mg/day in divided doses
Epilepsy (adults ≥12 years):
- Starting: 300 mg three times daily
- Maintenance: 300-600 mg three times daily
- Maximum: 2400 mg/day (well-tolerated); up to 3600 mg/day studied
Clinical Reality and Recommendations
If you are considering gabapentin for anxiety, you should instead use evidence-based treatments:
- First-line for anxiety disorders: SSRIs (sertraline, escitalopram, fluoxetine) or SNRIs (duloxetine, venlafaxine) 3
- Duloxetine specifically has FDA approval for generalized anxiety disorder at 60-120 mg/day 2
- Cognitive behavioral therapy alone or in combination with medication 3
Important Caveats
- Off-label use carries risks: The geriatric literature 9 specifically warns about increased falls, fractures, respiratory depression, cognitive impairment, and atrial fibrillation with gabapentinoids in older adults
- Sedation is common and dose-dependent 2, 10, which may be mistaken for anxiolysis
- No established chronic dosing regimen exists for anxiety because this is not a studied or approved indication
- The single positive RCT mentioned for pregabalin (not gabapentin) in GAD in older patients 9 is insufficient to recommend gabapentinoids over established treatments
The evidence does not support prescribing gabapentin for anxiety disorders. Use medications with proven efficacy and FDA approval for this indication.